|
|
Article: Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board.
- Article from:
- Blood Weekly
- Article date:
- October 22, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Cornerstone Pharmaceuticals, Inc., a privately-held pharmaceutical company, announced that groundbreaking cancer research scientist Robert A. Weinberg, Ph.D., a founding member of the Whitehead Institute for Biomedical Research and a Professor of Biology at MIT, has joined the company's Scientific Advisory Board (see also Cancer).
Widely recognized for his discoveries of the first human oncogene (the ras oncogene that causes normal cells to form tumors), and the isolation of the first known tumor suppressor gene -- the Rb gene, Dr. Weinberg has long been recognized as a pioneer in cancer research.
"We are delighted to welcome Dr. Weinberg to our ...